Utama › Fibrosis Paru Idiopatik › California
Kajian klinikal Fibrosis Paru Idiopatik di California
13 kajian untuk Fibrosis Paru Idiopatik sedang mencari peserta di lokasi di California.
Bandar di California
Teks kajian rasmi (Bahasa Inggeris)
Remote Evaluation and Surveillance of Patients With Interstitial Lung Disease: Transforming ILD Care Delivery With Remote Monitoring
- University of California, San Francisco, San Francisco
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 5 Okt 2026 · NCT07673237An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
- University of Southern California, Los Angeles
- Newport Native MD, Inc., Newport Beach
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06951217A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
- Research Site, Loma Linda
- Research Site, Los Angeles
- Research Site, Newport Beach
- dan 2 lagi
Mengambil pesertaFasa 2
Umur 40 ke atas · Semua jantina · Dikemas kini 21 Sep 2026 · NCT07652658RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Kadima Neuropsychiatry Institute, San Diego
- Providence Medical Foundation, Santa Rosa
Mengambil pesertaFasa 2
Umur 18 hingga 80 · Semua jantina · Dikemas kini 15 Sep 2026 · NCT07002034Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets
- Newportnativemd, Inc., Newport Beach
- Palmtree Clinical Research, Palm Springs
- Paradigm Clinical Research Centers, Inc. - Redding, Redding
Mengambil pesertaFasa 3
Umur 40 ke atas · Semua jantina · Dikemas kini 14 Sep 2026 · NCT07671911A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
- University of Southern California, Los Angeles
- Cedars Sinai Medical Center, Los Angeles
- Paradigm Clinical Research Centers, LLC, San Diego
Mengambil pesertaFasa 2
Umur 40 ke atas · Semua jantina · Dikemas kini 4 Sep 2026 · NCT06968845Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)
- Palmtree Clinical Research Inc., Palm Spring
- Paradigm Clinical Research Centers LLC, Redding
Mengambil pesertaFasa 3
Umur 40 ke atas · Semua jantina · Dikemas kini 3 Sep 2026 · NCT07284602Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)
- University of California San Francisco, San Francisco
Mengambil pesertaFasa 2
Umur 40 ke atas · Semua jantina · Dikemas kini 2 Sep 2026 · NCT05571059Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
- University of California - Los Angeles, Los Angeles
- University of Southern California, Los Angeles
- Stanford University, Stanford
Mengambil pesertaKajian pemerhatian
Umur 21 ke atas · Semua jantina · Dikemas kini 12 Ogo 2026 · NCT01915511Dose-Escalation Study of Artesunate Patients With IPF
- Stanford University, Stanford
Mengambil pesertaFasa 1
Umur 40 ke atas · Semua jantina · Dikemas kini 11 Ogo 2026 · NCT05988463WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
- WISPer Site in Los Angeles, CA, Los Angeles
- WISPer site in Newport Beach, CA, Newport Beach
- WISPer Site in Palm Springs, CA, Palm Springs
Mengambil pesertaFasa 2
Umur 40 ke atas · Semua jantina · Dikemas kini 10 Ogo 2026 · NCT06967805Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
- Keck School of Medicine of USC, Los Angeles
Mengambil pesertaFasa 2
Umur 40 ke atas · Semua jantina · Dikemas kini 12 Nov 2025 · NCT05975983Zinc and Nicotinamide Riboside for Idiopathic Pulmonary Fibrosis
- Cedars-Sinai, Los Angeles
Mengambil pesertaFasa 2
Umur 50 ke atas · Semua jantina · Dikemas kini 10 Nov 2025 · NCT06567717Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.